Imagine noticing a crack in a wall long before the plaster falls. That crack can tell you where the house is weaker, if you know how to read it. Scientists at the University of Oslo say the brain may leave similar, subtle marks of Alzheimer’s disease years before our usual scans show the classic plaques.
Using almost two decades of repeated MRI scans, researchers tracked cognitively healthy adults and then mapped when amyloid plaques first appeared on PET imaging. The surprising pattern: changes in brain structure showed up at least seven years earlier than the first detectable plaque on amyloid-PET.
"We found structural changes in the brain many years before high levels of plaque are seen on PET scans," says James Michael Roe, who led the work while at the Center for Lifespan Changes in Brain and Cognition and is now International Scientific Lead at Cercare Medical. Short. Stark. Convincing.
The study did not chase people already showing memory problems. Instead, it looked back through MRI records of older adults who were still functioning normally. That retrospective lens allowed investigators to compare scans from the decade preceding plaque detection with scans of those who never developed plaques, revealing subtle shrinkage and tissue differences that had gone unnoticed.
Dementia can be detected earlier than previously assumed, new research shows. Here is conductor Kim Wigaard during a rehearsal with the popular Dementia Choir. The NRK series received the The University of Oslo Human Rights Award.
Anders Martin Fjell, head of the LCBC, calls the finding ``groundbreaking.'' He points out that these were cognitively well people, yet their brains bore early signatures that would later be associated with Alzheimer’s. Does this mean the disease has been whispering to us long before it shouts? The evidence says yes.
Why does this matter? Because amyloid-PET is widely regarded as the gold standard for identifying early Alzheimer's changes, and treatments and trials are often built around that benchmark. If structural MRI can flag earlier alterations, our search for the disease's true starting point should widen. Perhaps the processes that lead to plaques are already underway, or perhaps other biological cascades — inflammation, vascular changes, protein misfolding beyond amyloid — are at play even earlier.
"These findings suggest that there are brain changes that precede the first detectable signs of plaque accumulation," Fjell explains, adding a note of caution: the results open possibilities, not answers. If non-amyloid mechanisms drive the earliest damage, therapies focused solely on removing amyloid might miss the window where intervention could have the most impact.
The team’s approach — long-term MRI follow-up paired with later PET confirmation — is a reminder that time is a powerful laboratory. Sitting still and watching people over years produces insights a cross-sectional snapshot cannot. It’s also a nudge to clinicians and drug developers: expanding biomarkers and widening the biological targets could change who gets treated and when.
There’s still work to do. Larger cohorts, diverse populations, and combined measures of blood biomarkers, PET, and high-resolution MRI will be needed to confirm how early and how reliably these structural changes predict later amyloid accumulation and clinical decline. But this study reframes a simple question: is amyloid the first domino, or just a middle one?
If the brain whispers years before it shouts, are we listening soon enough?
Leave a Comment
Comments
No comments yet. Be the first.